Related Experiment Video

Updated: Jun 18, 2025

Perspectives on Neuroscience
00:26

Perspectives on Neuroscience

Published on: July 31, 2007

4.9K

From Other Journals: A Review of Recent Articles by Our Editorial Team

Kamel Shibbani1, Aditi Gupta2,3, Tarek Alsaied4,5

  • 1Rady Children's Hospital, University of California San Diego, San Diego, CA, USA.

Pediatric Cardiology
|August 2, 2024
PubMed

Insights

This review summarizes recent pediatric cardiology research, covering AI in fetal echocardiography, Apixaban for preventing blood clots in congenital heart disease, cardiovascular risks in childhood cancer survivors, and updated cardiac catheterization guidelines.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Medicine
  • Medical Technology

Background:

  • Keeping abreast of the latest research is crucial for pediatric cardiologists.
  • Recent publications cover diverse and critical areas within the field.
  • A consolidated summary aids in efficient knowledge acquisition.

Purpose of the Study:

  • To provide a concise overview of recent, impactful articles for pediatric cardiologists.
  • To highlight key advancements in fetal echocardiography, thromboembolism prevention, and cardiovascular health in specific pediatric populations.
  • To disseminate information on updated consensus statements relevant to congenital heart disease management.

Main Methods:

  • Literature review of recently published articles.
  • Synthesis of findings from diverse subspecialty areas.
  • Focus on articles relevant to clinical practice and guideline updates.

Main Results:

  • Artificial intelligence (AI) is emerging as a tool in fetal echocardiography.
  • Apixaban shows potential in preventing thromboembolism in pediatric congenital heart disease.
  • Childhood cancer survivors face significant cardiovascular event risks.
  • New consensus statements offer updated guidance on cardiac catheterization.

Conclusions:

  • The field of pediatric cardiology is rapidly evolving with technological and therapeutic advancements.
  • Early identification and management of cardiovascular risks in pediatric populations are paramount.
  • Adherence to updated guidelines is essential for optimal patient outcomes.

Related Concept Videos